You have a portfolio company that hit plan on cost but is stalling on revenue. The forecast the CFO showed the board last quarter has already slipped, and the reasons keep changing. Sales blames marketing lead quality. Marketing blames sales follow-up. The CRM says one thing, the finance model says another, and nobody can tell you, in a single meeting, what a dollar of new pipeline actually costs to produce or how reliably it converts. As an operating partner or a portfolio company executive, you are the one who has to decide where GTM dollars go next, and whether the go-to-market motion is a growth engine you can underwrite or a leaky pipe you keep patching.
This guide is about GTM value creation for portfolio companies from the buyer’s seat. Not the theory. The decisions you actually have to make, in order, and how to judge whether the work is producing enterprise value or just producing activity.
1. Why GTM Is Where the Value Creation Thesis Gets Tested
Cost takeouts are finite and mostly one-time. Revenue is where the multiple lives, and it is also where most value creation plans quietly underdeliver. Bain’s annual private equity work has documented for years that revenue and margin expansion, not multiple arbitrage or leverage, now carry the bulk of returns in a higher-rate environment. You can read the running thesis in Bain & Company’s Global Private Equity Report. When entry multiples are full, the return has to come from the operating build, and GTM is the largest, least-instrumented part of that build in most mid-market companies.
The trap is that GTM feels like it is working because there is a lot happening. Campaigns run. Reps make calls. The website ships. None of that is the number the deal thesis needs. As entry pricing compresses, where returns actually have to come from shifts toward operations, and GTM sits at the center of that shift. Your job is not to admire the activity. It is to decide whether the motion produces predictable, growing, profitable revenue, and to hold it to that standard.
This matters most at three moments: the first board meeting where the forecast is questioned, the point in the first 100 days where you set the operating priorities, and any moment the top line diverges from plan. If you are reading this because one of those is live, start with the baseline in section three.
2. Separate Revenue Growth From Revenue Noise
Before you spend a dollar on GTM improvement, you need to know what you are actually looking at. Most mid-market revenue reporting mixes together things that behave very differently, and treating them as one number is how forecasts break.
The four revenue components you should be able to see separately
- New logo revenue, which is the hardest to forecast and the most expensive to produce.
- Expansion revenue from existing accounts, usually the cheapest growth and the most under-instrumented.
- Renewal or repeat revenue, the base you are betting the hold period on.
- Churn and contraction, which quietly eats the growth the other three produce.
If the company reports a single blended growth number and cannot decompose it into these four, you do not have a GTM problem yet, you have a visibility problem. Fix the visibility first. You cannot judge a motion you cannot see. This is the same discipline that separates value-relevant risk from theater in diligence generally: the headline number tells you little until you decompose it.
3. Establish the GTM Baseline Before You Fund Anything
The single most common mistake I see operating teams make is funding GTM initiatives before establishing what the current motion actually produces. You end up unable to attribute any improvement, because there was never a clean starting line.
A defensible GTM baseline answers, with evidence and not opinion, a short list of questions:
- What does it cost to acquire a customer, fully loaded, by channel and by segment?
- What is the conversion rate at each stage, from first touch to closed revenue, and how long does each stage take?
- What is net revenue retention, and how does it trend by cohort?
- What is the ratio of pipeline coverage to quota, and is it real pipeline or hopeful pipeline?
- Which channels and segments are profitable at the margin, and which are subsidized by the rest?
If the company cannot answer these from its own systems in a week, that is your first finding. It usually points to a data and instrumentation problem that predates you. This is the same territory you cover during technology due diligence, where the question is whether the systems can actually tell you the truth about the business. If diligence flagged weak revenue instrumentation and the deal closed anyway, the baseline is your first 100-days workstream, not a nice-to-have.
McKinsey’s private capital research has repeatedly made the point that the portfolio companies that outperform are the ones that instrument their commercial engine early and manage it as a system rather than a set of departments. You can follow that body of work through McKinsey’s private capital insights. The instrumentation is not overhead. It is the thing that lets you decide.
4. Decide Which GTM Lever Actually Moves the Thesis
Not every GTM problem is worth solving in your hold period. The discipline is choosing the one or two levers that move the specific number your thesis depends on, and ignoring the rest until those are working.
There are really only a handful of levers, and they trade off against each other:
Acquisition efficiency
Lowering the cost and shortening the time to acquire a customer. High leverage when the company already converts well but pays too much for demand. Low leverage when the product or positioning is the actual constraint.
Conversion and sales productivity
Getting more revenue out of the pipeline you already generate. Usually the fastest payback, because it does not require more spend, only better process, better routing, and better rep enablement. This is where RevOps earns its keep.
Expansion and retention
Growing existing accounts and reducing churn. The cheapest growth per dollar and the most durable, which matters more the longer you hold. As longer hold periods move the value creation burden onto the operator, retention economics move from a footnote to a central lever.
Pricing and packaging
Often the highest-margin lever and the most neglected, because it feels risky and touches every part of the business. When it works, it drops almost straight to EBITDA.
Pick based on where your baseline shows the biggest gap between what the motion does and what the thesis needs. In an illustrative case, a company converting at industry norms but paying twice the peer cost per lead has an acquisition problem, not a sales problem, and the fix is upstream of the sales team entirely. Get the diagnosis wrong and you will spend a year fixing the department that is loudest rather than the one that is binding.
5. Instrument RevOps So the Number Is Trustworthy
None of the levers above matter if you cannot trust the reporting. RevOps is the connective tissue between marketing, sales, and customer success, and in most mid-market portfolio companies it is either missing or bolted on as an afterthought. That is why the forecast keeps slipping: the number is assembled from disconnected systems that each tell a slightly different story.
Three things have to be true for the number to be trustworthy:
- One source of truth for the funnel. If marketing, sales, and finance each maintain their own count of pipeline, you will never reconcile the forecast. This is why CRM consolidation across a portfolio company is so often the unglamorous prerequisite to any GTM improvement.
- Consistent stage definitions. A qualified lead has to mean the same thing on Monday as it did last quarter, or your conversion rates are fiction.
- Attribution that finance will accept. Not perfect attribution, which does not exist, but a defensible, consistent method the CFO can put in the model without hedging.
When you buy this capability from outside, ask hard questions before you sign. There is a useful checklist in the piece on what private equity should ask a RevOps consultant, and it applies whether the work is internal or vendor-led. The wrong answer is a consultant who sells you activity: dashboards, campaigns, hours. The right answer connects the work to a number you can put in front of the board.
6. Sequence the First 100 Days for GTM
GTM value creation has an order, and getting the order wrong wastes the most valuable window you have. The first 100 days set the operating tempo and the expectations, and the temptation is to launch initiatives before you can measure them. Resist it.
Days 0 to 30: see clearly
Establish the baseline from section three. Consolidate reporting into one funnel view. Interview the front line, not just the leadership, about where the motion actually breaks. Do not fund anything yet.
Days 30 to 60: decide the lever
Pick the one or two levers from section four that your baseline says are binding. Assign a single owner to each with a clear decision right and a specific metric they are accountable for. Diffuse ownership is why GTM initiatives stall.
Days 60 to 100: run one motion end to end
Pick a single segment or channel and improve the full motion for it, from demand through close through expansion, so you can prove the mechanism works before scaling it. A narrow, complete win beats a broad, half-finished rollout every time, and it gives you a defensible number for the first board meeting.
BCG’s work on principal investors makes a version of this point repeatedly: the value creation plans that land are the ones with clear ownership and a short list of measured priorities, not a long menu of intentions. Their principal investors and private equity research is collected at BCG’s site. The plan that lists twenty initiatives is a plan that will execute none of them well.
7. Judge the Work by Financial Outcome, Not Activity
This is the part where most GTM spend goes wrong, and it is the part you personally control. The vendor register of GTM activity is long and seductive: leads, MQLs, traffic, campaigns shipped, sequences built, dashboards launched. None of it is value creation. Value creation is a change in one of a small number of financial outcomes.
Hold every GTM investment to one of these:
- Revenue growth that shows up in the actual-versus-plan, not the pipeline slide.
- EBITDA expansion, because the growth came without a proportional increase in cost to acquire.
- Cash-flow improvement, from shorter sales cycles or better collection terms tied to the motion.
- Reduced forecast risk, so the CFO’s number stops slipping and the board stops discounting it.
- A higher exit multiple, because the growth is now predictable and instrumented enough for a buyer to underwrite.
Be honest about which category a claimed win falls into. Realized revenue is not the same as forecast revenue, and enabled capacity is not the same as either. When someone reports a GTM win, ask which it is: money in the bank this quarter, run-rate you can annualize, forecast you are projecting, or capability you have built for later. All four are legitimate. Presenting the last three as the first is how boards lose trust in the operating team.
The Harvard Law School Forum on Corporate Governance publishes ongoing work on how value creation gets measured and reported in private equity, and the discipline it describes maps directly onto GTM: distinguish what has been realized from what is projected. That body of work sits at the Harvard Law forum.
8. Connect GTM to the Exit Story, Not Just the Quarter
The best reason to instrument GTM properly is that it changes what a future buyer will pay. A company with predictable, decomposable, well-attributed revenue growth is worth more than one with the same growth and no visibility into how it happens, because the buyer can underwrite the former and has to discount the latter.
How you build GTM depends on the return engine. A growth-equity thesis versus a buyout thesis asks different things of the go-to-market motion: one is buying acceleration, the other is buying reliability and margin. The hold structure matters too. Under a GP-led continuation vehicle or a longer-hold thesis, the durability of the revenue engine matters more than the sprint, because you are underwriting the motion over more years and more market conditions.
PitchBook’s research and data give a sense of how buyers value revenue quality and how it moves multiples across sectors; their research hub is at PitchBook. S&P Global Market Intelligence covers the deal environment and multiple trends that determine how much revenue quality is worth at any given moment, tracked at S&P Global. And Harvard Business Review’s ongoing coverage of mergers and acquisitions is a good reality check on how the growth story survives contact with a buyer’s diligence, collected under HBR’s M&A topic. The through-line across all of them: predictable revenue commands a premium, and predictability is built, not wished for.
9. Handle the Special Cases: Carve-Outs and Distressed
Two situations bend the standard playbook enough to call out.
Carve-outs
When a division becomes a standalone company, its GTM motion usually leaves behind the parent’s brand, shared demand engine, and CRM. You are often starting the instrumentation from zero, and the baseline you inherit is contaminated by allocated parent-company costs and shared pipeline. Budget for standing up GTM as new infrastructure, not tuning an existing one. The dynamics of turning an orphaned division into standalone value are covered in the piece on corporate carve-outs, and GTM is frequently the hardest part of the separation.
Distressed and special situations
When you buy into a down cycle, the GTM priority inverts. Retention and cash conversion come first, and new-logo acquisition can wait. The temptation to buy growth to prove the thesis is strong and usually wrong when cash is tight. The window itself is the opportunity, as covered in distressed and special situations, but the GTM discipline it demands is defensive first.
10. Read the GTM Numbers Without Being Fooled
The same skepticism you apply to fund-level returns applies to GTM metrics. A growth number without context is as misleading as an IRR without a DPI. The discipline of reading IRR, MOIC and DPI without being fooled transfers directly: always ask what the number excludes and what assumptions it rests on.
Specific traps to watch for in GTM reporting:
- Vanity pipeline. Coverage ratios built from stale or unqualified opportunities that will never convert.
- Blended CAC. A company-wide acquisition cost that hides one profitable channel subsidizing three unprofitable ones.
- Cohort masking. Net revenue retention that looks healthy because a few large accounts offset broad small-account churn.
- Attribution shopping. Switching attribution models until the favored channel looks good.
For the broader market context that lets you sanity-check whether a portfolio company’s GTM performance is actually strong or just strong-looking, Preqin’s alternative assets data and the trade coverage in Private Equity International and Buyouts are useful references. Preqin’s data hub is at Preqin. On reporting standards for how you present all of this to an investment committee, the AICPA & CIMA guidance is worth knowing, and where disclosure crosses into regulated territory, the SEC is the authority, though nothing here is legal or investment advice.
11. A Decision Checklist for the Operating Partner
Before you fund, launch, or renew any GTM initiative in a portfolio company, run it against this list. If you cannot answer yes, you are not ready to spend.
- Have I decomposed revenue into new logo, expansion, renewal, and churn, and can I see each separately?
- Do I have a clean GTM baseline with fully loaded CAC, stage conversion, and net revenue retention by cohort?
- Have I picked the one or two levers that move the specific number my thesis needs, and ignored the rest?
- Is there one source of truth for the funnel that marketing, sales, and finance all reconcile to?
- Does every initiative have a single owner with a decision right and one metric they own?
- Can I state which financial outcome each investment moves, and classify it as realized, run-rate, forecast, or enabled?
- Would this GTM story survive a buyer’s diligence, or does it depend on numbers I cannot defend?
12. What to Do This Quarter
If your portfolio company’s forecast keeps slipping, do not start with a new campaign or a new head of sales. Start with visibility. Decompose the revenue, build the baseline, and put the funnel on one source of truth. Then, and only then, pick the lever that moves your number and give it one owner. That sequence, seeing clearly before spending, is what separates GTM value creation for portfolio companies from GTM spending that generates reports.
The operating teams that win the revenue line are not the ones with the most activity. They are the ones who can walk into a board meeting and say, with evidence, exactly what a dollar of growth costs, how reliably it converts, and which number they are moving next. That is a decision discipline, not a marketing budget. And it is the difference between a growth story a buyer will pay a premium for and one they will discount.
If you want to put that discipline into a portfolio company on a fixed timeline, with the funnel instrumentation, the baseline, and the RevOps operating cadence built for you, look at the DevriX full-funnel demand and RevOps engagement for private equity portfolio companies. It is built to produce a defensible number, not a longer to-do list.